A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
Clinical trial NCT05068609 · COMPLETED
Trial details
- NCT number
- NCT05068609
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-13
- Primary completion
- 2021-10-18
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.